1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics in Oceania Countries, June 2015 (p6)

Pharmaceutical Analysis & Statistics in Oceania Countries, June 2015 (p6)

151-180 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

My Chemist Group in Consumer Health (Australia)

My Chemist Group in Consumer Health (Australia)

  • $ 428
  • Company report
  • June 2015
  • by Euromonitor International

My Chemist Group is currently the largest retail distributor of consumer health products in Australia, predominately through its Chemist Warehouse brand. Its positioning as a low-cost alternative to traditional ...

  • Industries : OTC
  • Countries : Australia
Blackmores New Zealand Ltd in Consumer Health (New Zealand)

Blackmores New Zealand Ltd in Consumer Health (New Zealand)

  • $ 428
  • Company report
  • June 2015
  • by Euromonitor International

Blackmores (New Zealand) Ltd is expected to focus on widening its product offering, with a particular focus on sports nutrition and weight management. The company will also continue to concentrate on achieving ...

  • Industries : OTC
  • Countries : New Zealand
PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2023

  • $ 10995
  • Industry report
  • April 2015
  • by GlobalData

PharmaPoint: Melanoma - Global Drug Forecast and Market Analysis to 2023 Summary Melanoma is the deadliest and most aggressive form of skin cancer. The major treatments for melanoma are categorized into ...

  • Industries : Therapy
  • Countries : World, Europe, United States, Japan, Australia
Melanoma - Current and Future Players

Melanoma - Current and Future Players

  • $ 2995
  • Industry report
  • April 2015
  • by GlobalData

Melanoma - Current and Future Players Summary GlobalData has released its pharma report, “Melanoma - Current and Future Players”. The report is a vital source of up-to-date information with in-depth ...

  • Industries : Therapy
  • Countries : United States, United Kingdom, World, Australia
Melanoma - Australia Drug Forecast and Market Analysis to 2023

Melanoma - Australia Drug Forecast and Market Analysis to 2023

  • $ 4995
  • Industry report
  • April 2015
  • by GlobalData

Melanoma - Australia Drug Forecast and Market Analysis to 2023 Summary Melanoma is the deadliest and most aggressive form of skin cancer. The major treatments for melanoma are categorized into immunotherapies ...

  • Industries : Therapy
  • Countries : World, Australia
Pharmaceutical, Laboratory and Hygienic Glassware Market in New Zealand to 2019 - Market Size, Trends, and Forecasts

Pharmaceutical, Laboratory and Hygienic Glassware Market in New Zealand to 2019 - Market Size, Trends, and Forecasts

  • $ 652
  • Industry report
  • February 2015
  • by Global Research & Data Services

This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for pharmaceutical, laboratory and hygienic glassware in New Zealand. The research ...

  • Industries : Houseware, Pharmaceutical, Home Goods
  • Countries : New Zealand, World
Pharmaceutical, Laboratory and Hygienic Glassware Market in Australia to 2019 - Market Size, Trends, and Forecasts

Pharmaceutical, Laboratory and Hygienic Glassware Market in Australia to 2019 - Market Size, Trends, and Forecasts

  • $ 652
  • Industry report
  • February 2015
  • by Global Research & Data Services

This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for pharmaceutical, laboratory and hygienic glassware in Australia. The research includes ...

  • Industries : Houseware, Pharmaceutical, Home Goods
  • Countries : Australia
Healthcare Industry in Australia – PEST Framework Analysis

Healthcare Industry in Australia – PEST Framework Analysis

  • $ 220
  • Industry report
  • January 2015
  • by Aruvian's R'search

Healthcare is the prevention, treatment, and management of illness and the preservation of mental and physical well being through the services offered by the medical, nursing, and allied health professions. ...

  • Industries : Healthcare
  • Countries : Australia
PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023

  • $ 4995
  • Industry report
  • December 2014
  • by GlobalData

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the ...

  • Industries : Therapy, Pathology
  • Countries : Australia, Oceania
Sun Biomedical Limited (SBN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sun Biomedical Limited (SBN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2014
  • by GlobalData

Summary Sun Biomedical Limited (Sun Biomedical) is a publicly held Australia-based pharmaceutical company. The company through its subsidiaries engages in the research, development and manufacture of illicit ...

  • Industries : Pharmaceutical
  • Countries : Australia
Australia Advanced Wound Management Market Outlook to 2020

Australia Advanced Wound Management Market Outlook to 2020

  • $ 2500
  • Industry report
  • October 2014
  • by GlobalData

Australia Advanced Wound Management Market Outlook to 2020 Summary GlobalData’s new report, "Australia Advanced Wound Management Market Outlook to 2020", provides key market data on the Australia Advanced ...

  • Industries : Medical Supply
  • Countries : Australia, Oceania
Brain Resource Limited (BRC) - Product Pipeline Analysis, 2014 Update

Brain Resource Limited (BRC) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • October 2014
  • by GlobalData

Summary Brain Resource Limited (BRL) is a healthcare service provider. The company carries out research and development of brain products. Its products include MyBrainSolutions, MyCalmBeat, WebNeuro and ...

  • Industries : Therapy, Mental Health
  • Countries : Australia, United States
PharmaPoint: Asthma - Australia Drug Forecast and Market Analysis to 2023

PharmaPoint: Asthma - Australia Drug Forecast and Market Analysis to 2023

  • $ 4995
  • Industry report
  • August 2014
  • by GlobalData

PharmaPoint: Asthma - Australia Drug Forecast and Market Analysis to 2023 Summary Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented ...

  • Industries : Therapy
  • Countries : Australia
Pharmacybrands Ltd in Consumer Health (New Zealand)

Pharmacybrands Ltd in Consumer Health (New Zealand)

  • $ 131
  • Company report
  • July 2014
  • by Euromonitor International

Pharmacybrands Ltd is expected to continue expanding its retail network of chemists/pharmacies across New Zealand through its five banners; Amcal, Care Chemist, Radius Pharmacy, Life Pharmacy and Unichem. ...

  • Industries : OTC
  • Countries : New Zealand
QRxPharma Limited - Product Pipeline Review - 2014

QRxPharma Limited - Product Pipeline Review - 2014

  • $ 1500
  • Company report
  • June 2014
  • by Global Markets Direct

QRxPharma Limited - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘QRxPharma Limited - Product Pipeline Review - 2014’, provides an overview of the QRxPharma Limited’s pharmaceutical ...

  • Industries : Therapy
  • Countries : World, United States, China, Australia
Global Skincare Market: Merger and Acquisitions May 2014

Global Skincare Market: Merger and Acquisitions May 2014

  • $ 295
  • Industry report
  • June 2014
  • by GlobalData

Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global skincare market during May 2014. Summary Using ...

  • Industries : Body Care
  • Countries : United States, New Zealand, World
Sigma Pharmaceuticals Ltd in Retailing (Australia)

Sigma Pharmaceuticals Ltd in Retailing (Australia)

  • $ 131
  • Company report
  • June 2014
  • by Euromonitor International

After a successful redefinition of its business strategy, Sigma Pharmaceuticals has been focusing on strengthening its pharmacy-based retail business. In the first quarter of 2013, Sigma Pharmaceuticals ...

  • Industries : Pharmaceutical
  • Countries : Australia
Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3495
  • Industry report
  • May 2014
  • by GlobalData

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : World, Australia
ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3495
  • Industry report
  • May 2014
  • by GlobalData

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Therapy, Mental Health, Pathology
  • Countries : World, Australia
Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3495
  • Industry report
  • May 2014
  • by GlobalData

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Mental Health, Therapy, Pathology
  • Countries : Australia, World
Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3495
  • Industry report
  • May 2014
  • by GlobalData

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Mental Health, Therapy, Pathology
  • Countries : World, Australia, Japan
Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3495
  • Industry report
  • May 2014
  • by GlobalData

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Therapy, Mental Health, Pathology
  • Countries : World, Australia
Ego Pharmaceuticals Pty Ltd in Consumer Health (Australia)

Ego Pharmaceuticals Pty Ltd in Consumer Health (Australia)

  • $ 131
  • Company report
  • April 2014
  • by Euromonitor International

Ego Pharmaceuticals will continue to reinforce its dominant position in Australia while focusing on expansion within the Asia-Pacific region, the Middle East and the UK to drive additional value growth. ...

  • Industries : Pharmaceutical
  • Countries : Australia
Swisse Vitamins Pty Ltd in Consumer Health (Australia)

Swisse Vitamins Pty Ltd in Consumer Health (Australia)

  • $ 131
  • Company report
  • April 2014
  • by Euromonitor International

Swisse Vitamins Pty Ltd looks to continue its rapid expansion through focusing on international markets and continuing its strategy of engaging high profile brand ambassadors. Swisse has already ventured ...

  • Industries : OTC
  • Countries : Australia
Chemist Warehouse Ltd in Consumer Health (Australia)

Chemist Warehouse Ltd in Consumer Health (Australia)

  • $ 131
  • Company report
  • April 2014
  • by Euromonitor International

Chemist Warehouse will continue to position itself as a low cost alternative to community pharmacies to become the largest retail distributer in Australia. Chemist Warehouse will maintain its paradigm ...

  • Industries : OTC
  • Countries : Australia
Pharmaceuticals in New Zealand

Pharmaceuticals in New Zealand

  • $ 350
  • Industry report
  • April 2014
  • by MarketLine

Introduction Pharmaceuticals in New Zealand industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). ...

  • Industries : Pharmaceutical, Therapy, Pathology
  • Countries : New Zealand
Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability

Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability

  • $ 4995
  • Industry report
  • March 2014
  • by GBI Research

Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability Summary GBI Research, the leading business intelligence ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : Asia, India, China, Japan, Australia
Orphan Australia Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Orphan Australia Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by GlobalData

Summary Orphan Australia Pty Ltd (Orphan Australia) is a pharmaceutical company. The company provides novel therapies for the treatment of serious or life-threatening diseases in Australia and New Zealand. ...

  • Industries : Pharmaceutical
  • Countries : Australia
Pharmaceuticals in Australia: ISIC 2423

Pharmaceuticals in Australia: ISIC 2423

  • $ 604
  • Industry report
  • January 2014
  • by Euromonitor International

Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Pharmaceuticals market at ...

  • Industries : Pharmaceutical
  • Countries : Australia
Healthcare and Pharmaceuticals Report New Zealand 2013

Healthcare and Pharmaceuticals Report New Zealand 2013

  • $ 190
  • Industry report
  • November 2013
  • by The Economist Intelligence Unit

Disease trends;Healthcare;Healthcare;Healthcare;Pharmaceuticals and biotechnology;Healthcare;Spending and provision NCAIS: 62 SIC: 80

  • Industries : Healthcare
  • Countries : New Zealand

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.